Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 333-347 , April 2006

In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction

Received 29 September 2005 ,Revised 8 December 2005 ,Accepted 8 December 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(05)00301-X

doi: 10.1016/j.nucmedbio.2005.12.006

Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 333-347 , April 2006

Article Tools

* Image Usage & Resolution